L-arginine-derived nitric oxide: a major determinant of uveal blood flow

Exp Eye Res. 1993 Aug;57(2):129-34. doi: 10.1006/exer.1993.1107.

Abstract

The effect of inhibition of the L-arginine-nitric oxide pathway on regional ocular blood flow was studied in anaesthetized Beagle dogs. Under control conditions (mean arterial blood pressure 105 +/- 6 mmHg) trapping of 11 and 15-microns-diameter tracer microspheres revealed the following regional blood flows (ml min-1 g-1): retina 0.065 +/- 0.016, choroid 5.72 +/- 0.32, ciliary body 0.77 +/- 0.11, iris 0.18 +/- 0.04. After i.v. infusion of nitro-L-arginine methylester (20 mg kg-1), a potent inhibitor of nitric oxide production from L-arginine, mean arterial blood pressure increased from 105 +/- 6 mmHg by 19% to a new steady-state level of 125 +/- 7 mmHg. This increase of arterial blood pressure extended over 3 hr and was reversible after i.v. infusion of L-arginine (100 mg kg-1 over 10 min). Despite the increase in blood pressure following infusion of nitro-L-arginine methylester blood flow of choroid, ciliary body, and iris were significantly decreased by 40, 40 and 48%, respectively. Retinal blood flow did not change significantly (-12%). These results suggest that the L-arginine-nitric oxide pathway is of major importance for the adjustment of uveal blood flow under resting physiological conditions.

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / metabolism
  • Arginine / pharmacology
  • Ciliary Body / blood supply
  • Dogs
  • Iris / blood supply
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / metabolism*
  • Regional Blood Flow / drug effects
  • Retinal Vessels / physiology
  • Uvea / blood supply*

Substances

  • Nitric Oxide
  • Arginine
  • NG-Nitroarginine Methyl Ester